Atıf Formatları
Serum hypoxia-inducible factor-2: A candidate prognostic biomarker for laryngeal cancer
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

G. ESKİİZMİR Et Al. , "Serum hypoxia-inducible factor-2: A candidate prognostic biomarker for laryngeal cancer," Clinical Otolaryngology , vol.46, no.6, pp.1172-1183, 2021

ESKİİZMİR, G. Et Al. 2021. Serum hypoxia-inducible factor-2: A candidate prognostic biomarker for laryngeal cancer. Clinical Otolaryngology , vol.46, no.6 , 1172-1183.

ESKİİZMİR, G., ÇALIBAŞI KOÇAL, G., Uysal, T., ELLİDOKUZ, H., & Başpınar, Y., (2021). Serum hypoxia-inducible factor-2: A candidate prognostic biomarker for laryngeal cancer. Clinical Otolaryngology , vol.46, no.6, 1172-1183.

ESKİİZMİR, GÖRKEM Et Al. "Serum hypoxia-inducible factor-2: A candidate prognostic biomarker for laryngeal cancer," Clinical Otolaryngology , vol.46, no.6, 1172-1183, 2021

ESKİİZMİR, GÖRKEM Et Al. "Serum hypoxia-inducible factor-2: A candidate prognostic biomarker for laryngeal cancer." Clinical Otolaryngology , vol.46, no.6, pp.1172-1183, 2021

ESKİİZMİR, G. Et Al. (2021) . "Serum hypoxia-inducible factor-2: A candidate prognostic biomarker for laryngeal cancer." Clinical Otolaryngology , vol.46, no.6, pp.1172-1183.

@article{article, author={GÖRKEM ESKİİZMİR Et Al. }, title={Serum hypoxia-inducible factor-2: A candidate prognostic biomarker for laryngeal cancer}, journal={Clinical Otolaryngology}, year=2021, pages={1172-1183} }